PE-backed biotech platform launched

Pelican Life Sciences has emerged from the shadows with $100 million in financing from Grotech Capital and Ferrer Freeman.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this